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Abstract Platelet endothelial cell adhesion molecule-1 (PE-
CAM-1, CD31) is rapidly tyrosine phosphorylated in mechani-
cally stimulated vascular endothelial cells (ECs). A 65-kDa 
protein from ECs specifically bound to the c-Src phosphorylated 
PECAM-1 cytoplasmic domain and was identified as a protein 
tyrosine phosphatase SH-PTP2 (SHP2, Syp). PECAM-1 was 
coimmunoprecipitated by anti-SH-PTP2 from EC extracts as a 
major binding protein, and the level of association increased when 
PECAM-1 was tyrosine phosphorylated. This association was 
mediated by SH2 domains of SH-PTP2. A rapid translocation of 
SH-PTP2 into cell-cell adhesion sites, where PECAM-1 was 
localized, occurred in mechanically stimulated cells. Our results 
suggest that PECAM-1 is a component of a mechanosensing 
machinery acting upstream of SH-PTP2. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Molecular mechanisms for sensing and subsequent signal 
transduction of mechanical stimuli are largely unknown. Vas-
cular endothelial cells (ECs) are constantly exposed to me-
chanical forces, fluid shear stress and stretch, from flowing 
blood. These cells are thought to be able to sense both the 
magnitude and the direction of fluid flow [1,2]. Both in vivo 
and in vitro studies have revealed that E C responses to flow 
include changes in the secretion of vasoactive substances, gene 
expression and the cytoskeleton and cellular morphology (see 
[3] for a review). Recently, we found that a 128-kDa cell sur-
face glycoprotein was tyrosine phosphorylated within a min in 
ECs exposed to fluid flow, hyper- or hypo-osmotic shock and 
that this phosphorylation was independent of Ca 2 + mobiliza-
tion or P K C activation in these cells [4]. The 128-kDa glyco-
protein was then identified as platelet endothelial cell adhesion 
molecule-1 (PECAM-1, CD31) [5,6]. Our in vitro data sug-
gested an involvement of Src family kinases in this PECAM-1 
tyrosine phosphorylation [6]. PECAM-1 is an immunoglobu-
lin superfamily cell adhesion molecule [7] and is involved in 
cell-cell adhesion/recognition by homophilic and heterophilic 
binding mechanisms [8-11]. In ECs, PECAM-1 is concen-
trated at the region of cell apposition between neighboring 
cells [8,9]. Recently, PECAM-1 tyrosine dephosphorylation 
was reported to take place during integrin mediated cell 
spreading onto solid substrates [12]. This and our data suggest 
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that the levels of PECAM-1 tyrosine phosphorylation is regu-
lated by mechanical forces exerted to cells. 
Protein tyrosine phosphorylation plays principal roles in 
intracellular signaling and regulates various cellular functions. 
To characterize PECAM-1 mediated signaling, it is crucial to 
find out proteins specifically interacting with tyrosine phos-
phorylated PECAM-1 . Here, we show that tyrosine phos-
phorylated PECAM-1 is a major binding protein of SH-
PTP2 (also known as PTP1D, PTP2C, Syp, SHP2), a non-
transmembrane protein tyrosine phosphatase containing two 
Src homology 2 (SH2) domains [13], in mechanically stimu-
lated ECs. SH-PTP2 is known to act as a positive signaling 
molecule just downstream of receptor tyrosine kinases [14—17] 
and to activate Ras in the M A P kinase cascade [15,17]. Our 
findings suggest that one of the pathways for the activation of 
M A P kinases observed in mechanically stimulated ECs [18-
21] is mediated by the PECAM-1/SH-PTP2 interaction. 
2. Materials and methods 
2.1. Reagents and cells 
GST fusion proteins containing the cytoplasmic domain of bovine 
PECAM-1 (amino acid residues 625-738, GST-PECAM-lCyt) and its 
spliced-out form (residues 625-702/722-738, GST-PECAM-lCyt-
ΔΕχ14) were synthesized [6] using a pGEX-2TK vector (Pharmacia 
Biotech). GST fusion proteins containing two SH2 domains of SH-
PTP2, the SH2 domain of Fyn kinase, the SH2 domain of the PI3 
kinase p85a subunit, and the SH2-SH2-SH3 containing domain of 
PLCyl were obtained from Santa Cruz Biotechnology. Affinity puri-
fied antibodies against different regions of bovine PECAM-1 were 
described earlier [6]. Anti-SH-PTP2 (the C-terminus region) was the 
product of Santa Cruz Biotechnology. Anti-phosphotyrosine (clone 
4G10) was obtained from Upstate Biotechnology. c-Src and the cata-
lytic subunit of cyclic AMP dependent kinase (A-kinase) were ob-
tained from Upstate Biotechnology and Sigma, respectively. 
Bovine arterial ECs (BAECs) were cultured and stimulated by hy-
perosmotic condition as described previously with a slight modifica-
tion [4,6]. Briefly, cells were starved for 24-36 h in a low serum 
medium (DMEM/F12 containing 1% serum), preincubated for 2 min 
with 1 mM Na3"V04 in the same medium and treated for 3 min 
either with the same vanadate containing medium (control) or the 
same medium containing 0.3 M sucrose (hyperosmotic medium). Cells 
were washed with ice-cold PBS containing 1 mM Na3V04 and lysed 
in an ice-cold 50 mM Tris-HCl buffer, pH 7.3, containing 50 mM 
NaCl, 20 mM NaF, 2 mM EGTA, 2 mM EDTA, 1 mM Na3V04 , 
1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 μg/ml pep-
statin, 10 μg/ml E64 and 0.4% Triton X-100 (lysis buffer). The lysate 
was centrifuged at 15 000 X g for 20 min, and the supernatant (approx-
imately 1.2 mg/ml protein) was used for assays. 
2.2. Far Western assay 
The lysate was separated on a 10% SDS-PAGE gel, transferred 
onto a PVDF membrane, and the membrane was blocked by Tris-
buffered saline containing 5% nonfat dry milk, 1 mg/ml of GST and 
0.02% Tween 80, and then probed with 100 μg of radio-labeled GST 
or GST-PECAM-1 Cyt in the blocking solution. A Bioimage analyzer 
(BAS2000, Fuji Film) was used to visualize bound radioactive signals. 
GST and the fusion protein were labeled by A-kinase-catalyzed serine 
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phosphorylation or c-Src-dependent tyrosine phosphorylation using 
[γ-32Ρ]ΑΤΡ (7000 Ci/mole, add 100 μα/100 μg protein in 100 μΐ of 
the reaction mixture) as the donor. GST was not tyrosine phosphoryl-
ated by c-Src in our labeling condition (1 h at 4°C). 
2.3. Affinity purification and microsequencing of a c-Src phosphorylated 
GST-PECAM-lCyt binding protein 
Thirty μg of GST-PECAM-lCyt bound to glutathione-Sepharose 
4B beads were phosphorylated by 37 units of c-Src overnight at 4°C in 
50 mM HEPES buffer, pH 7.2, containing 50 mM NaCl, 5 mM 
MgCl2, 5 mM MnCl2, 1 mM DTT, 100 μΜ Na3V04 and 1 mM 
ATP. The beads were extensively washed with Tris-buffered saline 
containing 10 mg/ml phenylphosphate and 10 mM EDTA to remove 
c-Src and then incubated with the BAEC lysate obtained from 1 X109 
cells. The bound material was eluted with 15 mM glutathione in 100 
mM Tris-HCl buffer, pH 8.0, and analyzed on a 10% SDS-PAGE gel. 
A 65-kDa band, which bound specifically to the affinity column, was 
excised and the protein was digested in-gel [22] by TPCK-trypsin 
(Worthington Biochemical Corp.) after reductive carboxymethylation. 
Peptide fragments were separated by reverse phase HPLC (μΡνΡΰ C2/ 
C18 SC 2.1/10 column, Smart System, Pharmacia Biotech), and iso-
lated peptides were sequenced by automated Edman degradation us-
ing a 492 protein sequencer (Applied Biosystems). 
2.4. Coimmunoprecipitation 
The BAEC lysate, precleaned with 50 μΐ of protein A Sepharose 
beads per 1.5 ml lysate, was incubated with 5 μg of anti-PECAM-1 
external domain or anti-SH-PTP2 for 1 h at 4°C and further incu-
bated for 1 h with 10 μΐ of protein A Sepharose beads. After washing 
with the lysis buffer, the bound material was recovered in SDS-PAGE 
sample buffer, separated on 8% SDS-PAGE gels and electro-blotted 
to PVDF membranes. Blotted membranes were probed with chick 
anti-PECAM-1, anti-SH-PTP2 or anti-phosphotyrosine. Biotinylated 
secondary antibodies and [125I]streptavidin (Amersham) were used to 
visualize bound antibodies by a Bioimage analyzer. 
2.5. GST-SH2 binding assay 
Glutathione-Sepharose beads preincubated with 3 μg of each GST 
fusion protein containing SH2 and/or SH3 domains were incubated 
with 1 ml of the BAEC lysate for 1 h at 4°C. After 5 X washing with 
the lysis buffer, the bound material was recovered in 100 μΐ of 15 mM 
glutathione in 100 mM Tris-HCl buffer, pH 8.0, containing 10 mg 
bovine serum albumin and 0.1% sodium deoxy cholate, and then 
precipitated by 10% trichloro acetic acid. The precipitated material 
was used for an immunoblot assay using anti-PECAM-1 as the probe. 
2.6. Confocal laser scanning microscope 
Localization of SH-PTP2 in BAECs stimulated or non-stimulated 
by the hyperosmotic condition was examined by indirect immuno-
fluorescence microscopy using a confocal laser scanning microscope 
(GB200, Olympus). BAECs were fixed in MeOH for 15 min at -20°C, 
blocked with PBS containing 5% of nonfat dry milk, fish gelatin 
(Sigma) and normal goat serum, and stained with anti-SH-PTP2 or 
anti-PECAM-1 cytoplasmic domain. 
3. Results 
3.1. Tyrosine phosphorylated PECAM-1 cytoplasmic domain 
specifically interact with a 65-kDa protein in vitro 
Far Western blotting was used to find proteins specifically 
interacting with tyrosine phosphorylated P E C A M - 1 . A GST-
PECAM-1 cytoplasmic domain fusion protein, which had 
been phosphorylated by exogenous c-Src or A-kinase was 
used as the probe. The c-Src phosphorylated fusion protein 
bound to a 65-kDa band in the total BAEC lysate (Fig. 1A). 
However, when GST or G S T - P E C A M - l C y t was serine phos-
phorylated by A-kinase in the linker region of the fusion 
protein, no detectable binding occurred. Since G S T itself 
Fig. 1. A 65-kDa protein specifically binds to the tyrosine phosphorylated PECAM-1 cytoplasmic domain. (A) A detergent soluble fraction of 
non-stimulated BAECs is analyzed by Far Western blotting using a GST fusion protein containing the PECAM-1 cytoplasmic domain as the 
probe. A-kinase phosphorylated GST (lane 1), A-kinase phosphorylated GST-PECAM-lCyt (lane 2), c-Src phosphorylated GST (lane 3) and c-
Src phosphorylated GST-PECAM-lCyt (lane 4). (B) Proteins bound to the c-Src phosphorylated GST-PECAM-lCyt affinity matrix. A total ly-
sate from non-stimulated BAECs (1X 109 cells) was applied onto the matrix and bound proteins were resolved on a 10% SDS-PAGE gel and 
stained with Coomassie blue. Almost exclusive binding of 65-kDa polypeptide (double arrowheads) is apparent. This band was used for a mi-
crosequencing analysis. The 45-kDa band (arrowhead) is GST-PECAM-lCyt and the lower molecular weight bands (30-40 kDa) are its proteo-
lytic digests. (C) An in vitro autophosphorylation analysis of materials bound to c-Src phosphorylated GST-PECAM-lCyt (lanes 1 and 2, the 
band position is indicated by an arrowhead), non-phosphorylated GST-PECAM-lCyt (lane 3) and non-phosphorylated GST-PEC AM-lCyt-
ΔΕχ14 (lane 4, white arrowhead). Six and a half mg of the total detergent soluble fraction from non-stimulated BAECs were applied onto the 
affinity columns, each containing 10 μg of one of the fusion proteins (lanes 2-A). Lane 1 shows the remaining c-Src activity in the phosphoryl-
ated GST-PECAM-lCyt after an extensive wash with phenylphosphate containing buffer. The bound materials were phosphorylated for 20 min 
at 37°C using [γ-32Ρ]ΑΤΡ (30 μ α ^ pi ι ρ ΐ β , 100 μΜ cold ATP), resolved on a 10% SDS-PAGE gel after elution, and the gel was autoradio-
gramed. The 65-kDa protein (double arrowheads) bound specifically to the c-Src phosphorylated PECAM-1 cytoplasmic domain and was phos-
phorylated in vitro. 
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Fig. 2. PECAM-1 is an SH-PTP2 binding protein in BAECs. Immunoprecipitates from a BAEC lysate using anti-PECAM-1 or anti-SH-PTP2 
were probed with anti-phosphotyrosine (A), anti-PECAM-1 (B) or anti-SH-PTP2 (C). The same amount of PECAM-1 or SH-PTP2 was recov-
ered from non-stimulated control cells (—) and osmotically stimulated cells (+) (see reprobed lanes in B and C), while the levels of tyrosine 
phosphorylation of both PECAM-1 and SH-PTP2 (A) and the efficiency of coimmunoprecipitation (B and C) increased when cells were ex-
posed to the hyperosmotic condition for 3 min. Positions of two PECAM-1 bands, the SH-PTP2 band and Ig heavy chain are indicated by ar-
rowheads, double arrowheads and an asterisk, respectively. 
could not be phosphorylated by c-Src, this 65-kDa protein 
binding was due to tyrosine phosphorylation in the cytoplas-
mic domain of PECAM-1. 
When c-Src phosphorylated GST-PECAM-lCyt was used 
as an affinity ligand, a polypeptide with the same molecular 
weight was recovered from the BAEC lysate (Fig. IB). Bind-
ing of this 65-kDa polypeptide to the affinity matrix was de-
pendent on the tyrosine phosphorylation. Affinity matrices 
made by GST (data not shown), non-phosphorylated GST-
PECAM-lCyt or GST-PECAM-lCytAExl4, which lacked 18 
amino acids including the whole consensus tyrosine phospho-
rylation motif [6], could not retain the 65-kDa polypeptide 
(Fig. 1C). 
A number of protein kinases have been known to have an 
autophosphorylation activity. Whether or not the 65-kDa 
protein possessed this activity was tested by an in vitro auto-
phosphorylation assay of the material bound to the affinity 
matrices (Fig. 1C). Although the 65-kDa band was phos-
phorylated, judging from the amount of proteins in the 
SDS-PAGE gel (see Fig. IB), the phosphorylation level was 
roughly comparable to that of GST-PECAM-lCyt. This re-
sult suggests that the 65-kDa protein is not a kinase. How-
ever, the material bound to the tyrosine phosphorylated PE-
CAM-1 cytoplasmic domain actually contained certain kinase 
activities including one which effectively phosphorylated the 
PECAM-1 cytoplasmic domain. In contrast to the 65-kDa 
and the GST-PECAM-lCyt bands, two higher molecular 
weight phosphorylated bands showed much higher relative 
levels of phosphorylation, suggesting that these two polypep-
tides were the candidates for putative PECAM-1 kinases. 
Small amounts of these two high molecular weight bands 
were also found in the material bound to the non-phosphoryl-
ated PECAM-1 cytoplasmic domain. 
3.2. The 65-kDa protein is SH-PTP2 
We purified a total of 5 μg of the 65-kDa polypeptide from 
2 x l 0 9 BAECs using the affinity matrix, obtained peptide 
fragments by 'in-geP tryptic digestion, and then sequenced 
7 fragments. Obtained sequences were W6FHPNITG-
VEAENLLLTR (the number indicated the corresponding 
amino acid number of the human SH-PTP2 sequence [13], 
completely matched with the human sequence), N58TGDYY 
(complete match), W112FHGHLSGK (complete match), 
G133SFLVR (complete match), S140QSLPGDFVLSVR 
(one aa change from H to L), T414VWQYHFR (complete 
match) and V579YENVGLMQQQK (complete match). All 
except one were identical to different parts of the human 
SH-PTP2 sequence and the fragment that did not show per-
fect identity contained one substitution out of 13 residues. 
These fragments did not show such a level of homology 
with any other known sequences including SH-PTP1. This 
result strongly suggests that the 65-kDa protein is a bovine 
homologue of SH-PTP2. 
3.3. Tyrosine phosphorylated PECAM-1 is a major SH-PTP2 
binding protein in BAECs 
The association of PECAM-1 with SH-PTP2 was also ob-
served in living BAECs. By immunoprecipitation, PECAM-1 
was recovered as 128 and 110-kDa bands from BAECs. The 
110-kDa molecule most likely represented a PECAM-1 form 
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Fig. 3. SH2 domain dependent association between PECAM-1 and SH-PTP2 or Fyn kinase. The lysate from non-stimulated control cells (—) 
or osmotically stimulated cells (+) was applied onto affinity columns each containing 3 μg of various SH2 domains expressed as GST fusion 
proteins. The bound PECAM-1 (arrowhead) was detected by anti-PECAM-1 immunoblots. The stimulation-dependent increase in the bound 
PECAM-1 level is clear when GST fusion proteins containing two SH2 domains of SH-PTP2 (A) or the Fyn kinase SH2 domain (B, right 
lanes) are used as the affinity ligands, while no significant binding is detected when the SH2 domain of PI3 kinase p85 subunit (B, left lanes) 
or the SH2-SH2-SH3 domain of PLCyl (B, central lanes) is used. The amount of the 110-kDa PECAM-1 band varies among different cultures 
of BAECs [4,6]. 
with a lesser degree of glycosylation [6]. About 3-fold increase 
in the PECAM-1 tyrosine phosphorylation level was observed 
in ECs exposed to the hyperosmotic medium for 3 min (Fig. 
2A). Immunoprecipitates with anti-SH-PTP2 from hyperos-
motically stimulated BAECs contained an increased amount 
of PECAM-1 than that from the non-stimulated cells (Fig. 
2B). Reciprocally, anti-PECAM-1 immunoprecipitates 
showed a stimulus-dependent increase in the coimmunopre-
cipitated SH-PTP2 (Fig. 2C). When anti-SH-PTP2 immuno-
precipitates were probed with anti-phosphotyrosine, four ma-
jor bands, about 170, 128, 105-120 and 40 kDa, were apparent 
(Fig. 2A). Although the 110-kDa PECAM-1 band overlapped 
with the 105-120-kDa band, the 128-kDa PECAM-1 band 
was clearly detected. SH-PTP2 itself also showed an increased 
level of tyrosine phosphorylation in the stimulated cells (Fig. 
2A). These data demonstrate that tyrosine phosphorylation 
dependent interaction between PECAM-1 and SH-PTP2 
does take place in BAECs and that PECAM-1 is a major 
SH-PTP2 binding protein in these cells. 
3.4. Tyrosine phosphorylated PECAM-1 interacts with SH2 
domains 
The association of tyrosine phosphorylated PECAM-1 and 
SH-PTP2 may be mediated by binding between SH2 domains 
of SH-PTP2 and phosphotyrosine residue(s) of PECAM-1. To 
prove this, we examined the binding capacity of PECAM-1 to 
various SH2 domains expressed as GST fusion proteins. PE-
CAM-1 from the hyperosmotically stimulated BAECs showed 
increased binding to the SH-PTP2 (Fig. 3A) and the Fyn 
kinase SH2 domains (Fig. 3B) than that from control cells. 
PECAM-1 did not effectively bind to the PI3 kinase p85 SH2 
domain or the PLCy SH2-SH2-SH3 domain (Fig. 3B). GST 
alone or the Fyn kinase SH3 domain did not bind to PE-
CAM-1 (data not shown). Our data indicate that tyrosine 
phosphorylated PECAM-1 provides binding site(s) for SH2 
domains in a sequence specific manner as reported for various 
SH2 domain binding motifs [23]. 
3.5. SH-PTP2 translocates to cell-cell adhesion sites when ECs 
are osmotically stimulated 
PECAM-1 is known to be localized to cell-cell adhesion 
sites in ECs [8,9]. This localization pattern did not signifi-
cantly change when cells were mechanically stimulated (Fig. 
4A, B), at least during 5 min of the stimulation. SH-PTP2 is 
thought to be principally a cytoplasmic soluble protein [10] 
and we have found diffuse cytoplasmic staining with anti-SH-
PTP2 in non-stimulated BAECs (Fig. 4C). When BAECs were 
stimulated by hyperosmotic condition, anti-SH-PTP2 staining 
appeared at cell-cell adhesion sites (Fig. 4D), suggesting that 
SH-PTP2 translocated and anchored to cell-cell adhesion 
sites, presumably, by the association with tyrosine phospho-
rylated PECAM-1. 
4. Discussion 
In this study we have shown that tyrosine phosphorylated 
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Fig. 4. Stimulation dependent translocation of SH-PTP2 into cell-cell adhesion sites. Confocal immunofluorescence micrographs showing 
BAECs stained with anti-PECAM-1 (A and B, a single optical section at the cell-cell adhesion level) and with anti-SH-PTP2 (C and D, an ex-
tended focus image reconstructed from 11 optical sections separated by 0.6 μpiι intervals). PECAM-1 is distributed at cell-cell adhesion sites 
and this localization appears unchanged between non-stimulated control BAECs (A) and cells exposed to the hyperosmotic condition for 3 min 
(B). Although a diffuse cytoplasmic staining pattern of SH-PTP2 is principally unchanged by the osmotic stimulation, SH-PTP2 becomes local-
ized at cell-cell adhesion sites in the stimulated cells (D, arrowheads). This localization is hardly seen in non-stimulated control cells (C). Scale 
bar, 10 μpiι. 
PECAM-1 is a major protein that associates with SH-PTP2 in 
BAECs. Our results indicate a direct binding of the two mol-
ecules mediated by the SH-PTP2 SH2 domains. The cytoplas-
mic domain of bovine PECAM-1 contains six tyrosine resi-
dues and five of them are conserved among human ([7], 
M28526), bovine ([6], D82082), porcine (X98505) and murine 
([24], L06039) PECAM-1 forms. Two of them (Tyr690 and 
Tyr713 in the bovine form) are in a pYXX(L/V/I) sequence 
motif which is known as the consensus SH-PTP2 SH2 binding 
motif [23]. SH-PTP2 has two SH2 domains and the engage-
ment of both domains results in massive activation of its 
phosphatase activity [25] which may be essential for SH-
PTP2 mediated signal transduction [14,15,17]. Recently, 
SHP substrate 1 (SHPS-1) was purified as a major SH-PTP2 
binding protein from v-Src transformed rat fibroblasts [26]. 
SHPS-1, also reported as BIT (a brain immunoglobulin-like 
molecule with tyrosine-based activation motifs) [27], is a mem-
brane glycoprotein belonging to the immunoglobulin super 
family and has two pairs of tyrosine residues, Y408ADL-
a.a.20-Y432ASI and Y449ADL-a.a.20-Y473ASI, in the cyto-
plasmic domain. Ohnishi et al. [27] demonstrated that each 
of the two sequences acted as a motif for simultaneous bind-
ing of the two SH-PTP2 SH2 domains. The PECAM-1 se-
quence, Y690TEV-a.a.i9-Y713SEV, shows homology to the 
two sequences of SHPS-1, suggesting that PECAM-1 also 
provides a bivalent binding site for SH-PTP2. Detailed bind-
ing analyses of phosphotyrosine containing peptides to the N-
terminal SH2 domain of SH-PTP2 have shown that a group 
of peptides having (D/E/N/Q)pY(I/V/T)(D/E/N/Q)(L/V/I)(D/ 
E/N/Q)(hydrophobic residue) motifs represents the strongest 
binding site for the SH2 domain [28]. The PECAM-1 cyto-
plasmic domain of all the known species contains a com-
pletely matched motif sequence at around Y690, suggesting 
that pY690 binds to the N-terminal SH2 domain of SH-PTP2. 
PECAM-1 could not bind to the PLCy or the PI3-kinase 
SH2 domain but did to the Fyn kinase SH2 domain in a 
tyrosine phosphorylation dependent manner. The result is 
consistent with the sequence feature of the PECAM-1 cyto-
plasmic domain: there is no tyrosine residue in the consensus 
motif for the PLCy or the PI3-kinase SH2 domains [23], while 
both Y690TEV and Y713SEV of PECAM-1 fulfill the se-
quence requirement for the binding to Src family kinase 
SH2 domains: an acidic residue at the pY+2 and a hydro-
phobic one at the pY+3 position [23]. We have already shown 
that c-Src phosphorylates and binds to the PECAM-1 cyto-
plasmic domain in vitro [6]. The present result suggests that 
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this binding is mediated by the Src SH2 domain and that at 
least one of the PECAM-1 motifs has a dual specificity for 
SH2 binding. 
In ECs, PECAM-1 is localized at cell-cell adhesion sites and 
participates in inter-endothelial cell adhesion by homophilic 
and heterophilic binding mechanisms [8-10]. The cell-cell ad-
hesion site is also a cytoskeleton-plasma membrane attach-
ment site and has been proposed to be one of the possible 
locations where putative mechanosensing machineries are 
present [3,6]. Interestingly, the PECAM-1 tyrosine phospho-
rylation in mechanically stimulated ECs was inhibited in cells 
pretreated by an actin filament disrupting agent cytochalasin 
D but was potentiated by phalloidin pretreatment, an actin 
filament stabilizer (unpublished observation). These observa-
tions indicate cytoskeletal involvement in the PECAM-1 phos-
phorylation. Our data suggest that PECAM-1 is a component 
of a mechanosensing machinery in ECs acting upstream of 
SH-PTP2. 
When ECs are mechanically stimulated, such as fluid flow 
and osmotic shock, PECAM-1 is tyrosine phosphorylated and 
a portion of SH-PTP2 shifts its localization to the plasma 
membrane. We suggest that tyrosine phosphorylated PE-
CAM-1 on the plasm membrane provides anchoring sites 
for SH-PTP2 and possibly for Src family kinases. Significance 
of these molecular association in the mechanical stimulus-in-
duced signal transduction in ECs has not yet been elucidated. 
However, two possible roles can be suggested. One is activa-
tion of the MAP kinase cascade through the activation of SH-
PTP2. The other is activation of Src family kinases by SH-
PTP2-dependent dephosphorylation of their inhibitory C-ter-
minal phosphotyrosine residue (Y527 in c-Src) [29] and by 
competitive participation of the PECAM-1 SH2 binding mo-
tiffs) in the inhibitory intramolecular binding between the Src 
SH2 domain and the C-terminal phosphotyrosine residue [30]. 
Recent findings have demonstrated that ERK and JNK7 
SAPK are activated in ECs stimulated by fluid shear stress 
[18-21]. Requirement for tyrosine kinase activity [20,21] and 
dependency of Ras mediated signaling [21] were reported in 
these MAP kinase activation pathways. Our preliminary data 
showed that both p42 ERK and c-Src were also activated in 
hyperosmotically treated BAECs. We suggest that PECAM-1 
tyrosine phosphorylation mediated signaling participates, at 
least partly, in mechanical stimuli-induced MAP kinase acti-
vation in ECs. 
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